176 related articles for article (PubMed ID: 26522259)
1. Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition.
Ju R; Guo L; Li J; Zhu L; Yu X; Chen C; Chen W; Ye C; Zhang D
Cancer Lett; 2016 Jan; 370(2):232-41. PubMed ID: 26522259
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Mechanisms and a Rational Combinational Application of Carboxyamidotriazole in Fighting Pancreatic Cancer Progression after Chemotherapy.
Ju R; Fei K; Li S; Chen C; Zhu L; Li J; Zhang D; Guo L; Ye C
J Pharmacol Exp Ther; 2018 Oct; 367(1):20-27. PubMed ID: 30002095
[TBL] [Abstract][Full Text] [Related]
3. Synergism of ursolic acid derivative US597 with 2-deoxy-D-glucose to preferentially induce tumor cell death by dual-targeting of apoptosis and glycolysis.
Wang J; Jiang Z; Xiang L; Li Y; Ou M; Yang X; Shao J; Lu Y; Lin L; Chen J; Dai Y; Jia L
Sci Rep; 2014 May; 4():5006. PubMed ID: 25833312
[TBL] [Abstract][Full Text] [Related]
4. 2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors.
Wanyan Y; Xu X; Liu K; Zhang H; Zhen J; Zhang R; Wen J; Liu P; Chen Y
Molecules; 2020 Dec; 25(23):. PubMed ID: 33297583
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
Wu Y; Sarkissyan M; Mcghee E; Lee S; Vadgama JV
Breast Cancer Res Treat; 2015 Jun; 151(3):529-39. PubMed ID: 25975952
[TBL] [Abstract][Full Text] [Related]
6. Berberine combined with 2-deoxy-d-glucose synergistically enhances cancer cell proliferation inhibition via energy depletion and unfolded protein response disruption.
Fan LX; Liu CM; Gao AH; Zhou YB; Li J
Biochim Biophys Acta; 2013 Nov; 1830(11):5175-83. PubMed ID: 23872355
[TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
[TBL] [Abstract][Full Text] [Related]
8. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glioblastoma tumorspheres by combined treatment with 2-deoxyglucose and metformin.
Kim EH; Lee JH; Oh Y; Koh I; Shim JK; Park J; Choi J; Yun M; Jeon JY; Huh YM; Chang JH; Kim SH; Kim KS; Cheong JH; Kim P; Kang SG
Neuro Oncol; 2017 Feb; 19(2):197-207. PubMed ID: 27571886
[TBL] [Abstract][Full Text] [Related]
10. 2-Deoxy-d-Glucose Can Complement Doxorubicin and Sorafenib to Suppress the Growth of Papillary Thyroid Carcinoma Cells.
Wang SY; Wei YH; Shieh DB; Lin LL; Cheng SP; Wang PW; Chuang JH
PLoS One; 2015; 10(7):e0130959. PubMed ID: 26134286
[TBL] [Abstract][Full Text] [Related]
11. Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation.
Marín-Hernández A; Gallardo-Pérez JC; López-Ramírez SY; García-García JD; Rodríguez-Zavala JS; Ruiz-Ramírez L; Gracia-Mora I; Zentella-Dehesa A; Sosa-Garrocho M; Macías-Silva M; Moreno-Sánchez R; Rodríguez-Enríquez S
Arch Toxicol; 2012 May; 86(5):753-66. PubMed ID: 22349057
[TBL] [Abstract][Full Text] [Related]
12. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
13. Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma.
Eriksson JA; Wanka C; Burger MC; Urban H; Hartel I; von Renesse J; Harter PN; Mittelbronn M; Steinbach JP; Rieger J
J Neurochem; 2018 Feb; 144(4):421-430. PubMed ID: 29178334
[TBL] [Abstract][Full Text] [Related]
14. Non-thermal plasma with 2-deoxy-D-glucose synergistically induces cell death by targeting glycolysis in blood cancer cells.
Kaushik N; Lee SJ; Choi TG; Baik KY; Uhm HS; Kim CH; Kaushik NK; Choi EH
Sci Rep; 2015 Mar; 5():8726. PubMed ID: 25735798
[TBL] [Abstract][Full Text] [Related]
15. Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells.
Rodríguez-Enríquez S; Vital-González PA; Flores-Rodríguez FL; Marín-Hernández A; Ruiz-Azuara L; Moreno-Sánchez R
Toxicol Appl Pharmacol; 2006 Sep; 215(2):208-17. PubMed ID: 16580038
[TBL] [Abstract][Full Text] [Related]
16. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells.
Ben Sahra I; Laurent K; Giuliano S; Larbret F; Ponzio G; Gounon P; Le Marchand-Brustel Y; Giorgetti-Peraldi S; Cormont M; Bertolotto C; Deckert M; Auberger P; Tanti JF; Bost F
Cancer Res; 2010 Mar; 70(6):2465-75. PubMed ID: 20215500
[TBL] [Abstract][Full Text] [Related]
17. Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo.
Sottnik JL; Lori JC; Rose BJ; Thamm DH
Clin Exp Metastasis; 2011 Dec; 28(8):865-75. PubMed ID: 21842413
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
Knouzy B; Dubourg L; Baverel G; Michoudet C
J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
[TBL] [Abstract][Full Text] [Related]
19. Carboxyamido-triazole inhibits proliferation of human breast cancer cells via G(2)/M cell cycle arrest and apoptosis.
Guo L; Li ZS; Wang HL; Ye CY; Zhang DC
Eur J Pharmacol; 2006 May; 538(1-3):15-22. PubMed ID: 16696967
[TBL] [Abstract][Full Text] [Related]
20. The heme precursor 5-aminolevulinic acid disrupts the Warburg effect in tumor cells and induces caspase-dependent apoptosis.
Sugiyama Y; Hagiya Y; Nakajima M; Ishizuka M; Tanaka T; Ogura S
Oncol Rep; 2014 Mar; 31(3):1282-6. PubMed ID: 24366173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
